Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Beam Therapeutics Inc.

NASDAQ: BEAM · Life Sciences · 3 alerts · CIK 1745999

Share price
$20.94Close, Nov 16
Market cap
$2.17B
Shares outstanding
103.5MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Beam Therapeutics Inc. filings on SEC EDGAR ↗

8:09 PM ET Form 4
Insider Selling

Beam Therapeutics CEO John M. Evans Sells $1.19M of Stock

John M. Evans, CEO, sold 50,000 shares of Beam Therapeutics Inc. at $23.57 to $23.98 a share (average $23.77) in 2 transactions, worth $1.19M in total between Oct 15, 2026 and Oct 16, 2026. Shares held after the trade: 1,047,205 (-2.3%).

Value
$1.19M
Shares
50,000
Average price
$23.77
Role
CEO
Holding change
-2.3%
Trade date
Oct 15, 2026 to Oct 16, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.